Thanks, Clay. Good afternoon, everyone. Thank you for joining us today to discuss our third quarter 2023 financial results and our full year 2023 guidance. As always, I want to thank each one of our employees, of course, our company for their continued support of GrowGen. I'm grateful to our entire team for their continued hard work, dedication, and for being steadfast in executing our company's strategy. I'm pleased with GrowGen's third quarter results. And I'm happy to discuss the progress we've made to drive future growth and profitability, including the launch of our new ERP system and East region Distribution Center on July 1 and the success of our proprietary brands. Despite the ongoing challenges in our industry, which we have discussed extensively in the past, GrowGen remains in a strong financial position with sufficient liquidity to continue investing for growth, while putting profitability at the forefront of all we do. In the third quarter of 2023, we generated net revenue of 55.7 million, which represents a 13% decline over the second quarter of 2023, consistent with the expectations we communicated on our second quarter call. Gross margins improved 320 basis points to 29.1% versus the prior year's comparable quarter of 25.9% and improved 230 basis points from second quarter gross margins of 26.8%. We ended the third quarter with 66.6 million of cash, cash equivalents and marketable securities, no debt and 76 million of inventory on our balance sheet. Year-to-date, we've generated approximately 2.8 million of operating cash flow. While the federal legislative agenda has not moved definitively in our favor, it does seem to be getting more favorable. There's renewed optimism for federal reform with SAFE Act passing the Senate Committee on Banking and potentially heading to the Senate floor for a full vote. And if approved to the house, then the President. More importantly, there's excitement building around cannabis rescheduling. After the Department of Health and Human Services, recommended rescheduling cannabis from Schedule 1 to 3, which would remove the 280E tax penalty on licensed cultivators bringing hundreds of millions of dollars back into the cannabis industry. We expect that this will provide a major tailwind for our industry. With that said, our three main initiatives remain our primary focus, as we discussed last quarter, what that means in practical terms is, number one, we're continuing to bring to market innovative new products and growing our proprietary brand portfolio, attracting a larger customer base. Number two, we're building upon our ERP launch, instead of forming our technology and digital platforms. And number three, we're putting profitability at the forefront, focusing on margin expansion and profitable growth. Briefly on each of these, first, we remained committed to the expansion of our proprietary and distributed brands and we are very satisfied with the results. Proprietary products accounted for 7.4 million of retail and ecommerce sales in the third quarter of 2023, which is around 16.6% of our overall retail and ecommerce sales, up from 15% in the second quarter of 2023. Product launches include the introduction of the much anticipated new drip pad and nutrient line in Q4, delivering across efficient nutrient solution while not compromising on quality. We're expanding Power Si with an advanced granular range of beneficial microbial solutions to bolster plant health and optimize growth to be released to Q4. In Q3, we rolled out Char Coir coco coins, and during the propagation market, the harvest company, our consumer gardening initiative is finalizing a diverse product portfolio that includes the already launched premium gloves and pruners as well as a garden and the box kit, an all-in-one solution for gardening enthusiast that includes raised metal bed, soils, fertilizers, and a curated selection of organic seeds. Lastly, MMI Ags, introducing a single tier multiple bench and trade systems for indoor and greenhouse growers in Q4. Second, our ERP system has been rolled out across all key business verticals. Like many other ERP rollouts, ours has not been without its challenges, and it will take time before benefits fully materialize. We're confident in our internal team and their ability to manage through the transition. Encouragingly, most of the issues we've encountered have been relatively minor and we're pleased with the progress that has been made to-date. To further develop our key technology initiatives, we have strengthened our leadership team with the addition of a Senior VP of Technology, who comes to us with impressive credentials, and whose mandate includes during our technological advancements, and solidifying our digital infrastructure. And third, we're prioritizing profitable growth, which we believe we will obtain through our continued efforts to grow revenue, executor margin expansion strategies, and consolidate stores. We're constantly analyzing the business for additional optimization and cost savings opportunities and expect the continued benefit to flow through to our margins through remainder of 2023 and 2024. As part of these efforts, we continue to analyze the performance of our current stores with respect to redundancies in the footprint and non-performance. We closed and consolidated six retail locations in the third quarter and are in the process of consolidating closing six additional locations in the fourth quarter that we expect to be finalized in November. That said, we expect a lower operating expense base and aim to retain the key customers from consolidated locations on a revenue basis. Further with our recently implemented centralized distribution system, consolidation of shipments and storage, we will reduce our in-store inventory levels and ensure quicker deliveries. The SKU rationalization we executed in Q3 will now allow us to focus on high demand products and phasing out low performing SKUs. All these executables are positioning us to operate more effectively and efficiently. Turning to guidance for full year 2023, we are maintaining our guidance of net revenue in the range of 220 million to 225 million and adjusted EBITDA loss in the range of minus 4 million to minus 6 million. With that I will turn the call over to our CFO, Greg Sanders.